Cambridge Epigenetix has appointed Hayden Jeffreys as Chief Operating Officer (COO) and Dr Joanne Mason as Vice President (VP) of Biomarker Discovery.

Hayden is a senior level executive with 20 years of experience in the clinical diagnostics industry with specialisation in the molecular diagnostic and blood bank fields. Joanne holds a PhD from the University of Cambridge and sits on the MHRA Genomics for Diagnosis Forum, UK NEQAS for molecular genetics DNA extraction steering committee and Genomics England sequencing advisory board.